How many clinical trials are tracked of Nabiximols?

5 trials are tracked, 1 with published results.

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Radiology & Imaging Genetics & Precision Medicine Pulmonology & Critical Care Anesthesiology & Pain Medicine Nephrology Emergency Medicine Physical Medicine & Rehab Urology Hematology Ophthalmology Dermatology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

Nabiximols

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of Nabiximols

5 trials tracked of Nabiximols: 5 in phase 3 or 4 and 1 with published results. The most-cited published study has 3 citations.

5Trials tracked

5Phase 3 & 4

0Recruiting

1With published results

Phase distribution

Phase 3 5

Phase 3 Trial to Evaluate the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple Sclerosis Completed · 3 cited
Phase 3 A Two-Part Study of Sativex® Oromucosal Spray for Relieving Uncontrolled Persistent Pain in Patients With Advanced Cancer Completed
Phase 3 Long Term Safety of Sativex Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain Completed
Phase 3 Sativex® for Relieving Persistent Pain in Participants With Advanced Cancer Completed
Phase 3 Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer Completed

Showing the 5 most-cited and recently-updated of 5 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.